A new strategy for developing vaccines against cancer showed promise in a proof-of-concept study led by scientists at Weill Cornell Medicine, NewYork-Presbyterian and Heidelberg University Hospital.
Embark Veterinary, Inc. – a canine genetics startup company that graduated from Cornell’s McGovern Center incubator in late 2017 – announced $75 million in venture funding on July 26.
Students in the Weill Cornell Medical College Class of 2022 learned on national Match Day where they will be doing their internship and residency training – setting the stage for the next several years of their medical careers and lives.
As a CIFAR Azrieli Global Scholars, Baobao Zhang will investigate challenges governments face when addressing public perceptions of inequalities brought about by new technologies and Elizabeth Johnson will look into connections between infant nutrition and gastrointestinal health.
During National Public Health Week April 5-11, up to 10,000 seats are available in the new Citizen Public Health Leader Training Program developed by Cornell experts in partnership with New York state.
Paula Cohen, associate vice provost for life sciences, is leading an eight-year, $8 million, multi-institution grant to untangle the complex genetic rulebook for how sperm develops.
A Baker Institute for Animal Health study finds the antimicrobial properties of certain stem cell proteins could help treat skin infections that are resistant to antibiotics.
Simulations show the helmet, designed by the Esmaily Lab, prevents 99.6% of virus-containing droplets exhaled by medical patients from reaching the environment.
Weill Cornell Medicine researchers are using machine learning, a form of artificial intelligence, to shed light on genetic mutations associated with spina bifida.
Researchers at Weill Cornell Medicine have identified neurons that drive animal brains to initiate actions without prompting from food or prey – a big step toward solving a big unanswered questions in neuroscience.